SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...

1-3 The patients we currently treat are generally frail and elderly and are more likely to have vascular access issues. TAVR requires an extensive preoperative workup to determine the most appropriate ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

TAVR is usually performed in a hybrid catheterization laboratory/operating room, although some institutions perform the procedure in a regular catheterization laboratory that has rapid access to ...

Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise suggests ...

Advancements in healthcare infrastructure, particularly in developing economies, play a significant role in the TAVR Embolic protection market growth by improving access to TAVR embolic protection ...

UCLA first performed TAVR in 2012 and leads the nation in outcomes ... Thanks to the newest generation devices, UCLA uses "transfemoral" access in the large majority of patients.

The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...

Self-expanding valves (SEVs) are associated with less prosthesis-patient mismatch (PPM) in East Asian patients with small aortic annuli (SAA) undergoing TAVR, compared with balloon-expandable valves ...